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In C. elegans, four asymmetric divisions, beginning
with the zygote (P0), generate transcriptionally re-
pressed germline blastomeres (P1–P4) and somatic
sisters that become transcriptionally active. The pro-
tein PIE-1 represses transcription in the later germ-
line blastomeres but not in the earlier germline blas-
tomeres P0 and P1. We show here that OMA-1 and
OMA-2, previously shown to regulate oocyte matura-
tion, repress transcription in P0 and P1 by binding to
and sequestering in the cytoplasm TAF-4, a compo-
nent critical for assembly of TFIID and the pol II pre-
initiation complex. OMA-1/2 binding to TAF-4 is de-
velopmentally regulated, requiring phosphorylation
by the DYRK kinase MBK-2, which is activated at
meiosis II after fertilization. OMA-1/2 are normally de-
graded after the first mitosis, but ectopic expression
of wild-type OMA-1 is sufficient to repress transcrip-
tion in both somatic and later germline blastomeres.
We propose that phosphorylation by MBK-2 serves
as a developmental switch, converting OMA-1/2
from oocyte to embryo regulators.
INTRODUCTION
Germ cells retain developmental totipotency, whereas somatic
cells undergo developmental potential and proliferative restric-
tion, culminating in terminal differentiation. Primordial germ cells
(PGCs) are set aside early during development and kept quies-
cent until they are needed for reproduction (review Extavour
and Akam, 2003). In mice, PGCs are specified around E6.5, at
which time they become transcriptionally silent, concurrent with
the removal of chromatin modifications associated with tran-
scription and differentiation and the addition of other epigenetic
markers associated with silenced chromatin (review Surani et al.,
2004). In Drosophila and C. elegans, PGCs are specified much
earlier during embryogenesis by maternally supplied factors. In
Drosophila, before activation of zygotic transcription, the inclu-
sion of germplasm during the cellularization of a small numberof nuclei at the posterior pole specifies these cells as PGCs.
These PGCs remain transcriptionally repressed and lack epige-
neticmarkers associatedwith active chromatin (Kobayashi et al.,
1988; Seydoux and Dunn, 1997; Schaner et al., 2003).
In C. elegans, primordial germ cells are specified through a
series of four asymmetric divisions beginningwith the zygote, P0,
the first germline blastomere. Each division gives rise to a tran-
scriptionally repressed germline blastomere (P1–P4) and a corre-
sponding somatic sister cell that quickly becomes transcription-
ally active (Figure 1) (Seydoux and Dunn, 1997; Seydoux and
Fire, 1994). Transcriptional repression in C. elegans germline
blastomeres must, therefore, involve a mechanism that is either
very transient, or readily reversible. P4, the first germline-re-
stricted blastomere, divides symmetrically to generate Z2 and
Z3, which go on to generate the entire germline.
Transcriptional repression in germline blastomeres requires
maternally-supplied PIE-1 protein, which localizes exclusively to
germline blastomeres (Mello et al., 1996; Seydoux et al., 1996).
Studies using C. elegans embryos as well as mammalian tissue
culture cells demonstrated that PIE-1 can repress transcriptional
elongation (Batchelder et al., 1999; Ghosh and Seydoux, 2008;
Zhang et al., 2003). Progression from transcription initiation to
elongation requires phosphorylation of serine 2 (Ser2) within
heptapeptide repeats of the RNA polymerase II (pol II) C-terminal
domain (CTD) by the p-TEFb kinase complex (Komarnitsky et al.,
2000). A region of PIE-1 that resembles an unphosphorylatable
form of the CTD heptapeptide sequence serves as a competitive
inhibitor of Ser2 phosphorylation (Batchelder et al., 1999; Zhang
et al., 2003). A recent report shows that PIE-1 also inhibits tran-
scription initiation in germline blastomeres through an unknown
mechanism (Ghosh and Seydoux, 2008).
PIE-1 protein, although present at high levels from P0 to P4, is
only essential for transcriptional repression in P2 and P3, and
partially required in P4 (Seydoux and Dunn, 1997; Seydoux
et al., 1996). In pie-1 null mutant embryos, germline transcription
remains repressed in P0 and P1. In addition, phosphorylation at
serine 5 of pol II CTD, a modification required for promoter clear-
ance and transcription initiation, was detected at low levels in
P2, P3, and P4 but was not detected in P0 or P1 (Seydoux and
Dunn, 1997; Walker et al., 2001). These results indicate that (1)
transcription repression in P0 and P1 involves a mechanism(s)
independent of, or in addition to, PIE-1 and (2) that unlike P2–P4,
repression in P0 and P1 occurs prior to transcription initiation.Cell 135, 149–160, October 3, 2008 ª2008 Elsevier Inc. 149
PIE-1 contains twoCCCHTIS11 zinc fingers (Mello et al., 1996;
Varnum et al., 1989), domains that have been implicated in RNA
binding (Lai et al., 1999; Pagano et al., 2007). PIE-1 promotes
translation of the NOS-2 protein, a function ascribed to one of
the zinc fingers (Tenenhaus et al., 2001). OMA-1 and OMA-2
each also contain two TIS11 zinc fingers but otherwise share no
sequence similarity to PIE-1. OMA proteins are redundantly
required for oocyte maturation and the earliest stages of embry-
onic development (Detwiler et al., 2001; Lin, 2003; Nishi and Lin,
2005; Shimada et al., 2002). OMA-1 and OMA-2 are cytoplasmic
proteins detected only in oocytes and the very early embryo.
Unless otherwise noted, we will refer to OMA-1 and OMA-2 as
OMA-1/2. OMA-1/2 levels increase in the proximal oocytes, peak
in the maturing (1) oocyte and the one-cell embryo, and then
rapidly decrease after the first mitotic division (Detwiler et al.,
2001; Lin, 2003; Shimada et al., 2002). Timely degradation of
Figure 1. Schematic of C. elegans Hermaphrodite Gonad and Early
Embryonic Divisions
(A) Oocyte development and maturation schematized in one of the two gonad
arms. Germ nuclei (white circles) are in a syncitial cytoplasm of the gonad arm
before cellularization to form oocytes. The oocyte adjacent to the spermatheca
(1) undergoes maturation and is then immediately ovulated and fertilized.
(B) Early embryonic divisions, highlighting the germline precursors P0 to P4
(red) and their somatic sisters (green). Left, schematic; right, differential interfer-
ence contrast (DIC) images. Embryo images in this and all subsequent figures
are oriented with the anterior pole to the left. The scale bar represents 10 mm.150 Cell 135, 149–160, October 3, 2008 ª2008 Elsevier Inc.OMA proteins requires phosphorylation by a DYRK2 kinase,
MBK-2, at T239. Mutations that prevent or reduce phosphoryla-
tionat T239 lead to themaintenanceof highOMA-1 levelsbeyond
the one-cell stage and embryonic lethality (Nishi and Lin,
2005; Shirayama et al., 2006). Animals with reduced combined
OMA-1 and OMA-2 activity, as opposed to complete depletion,
are not fully penetrant for the oocyte maturation defects and do
produce some dead embryos (Nishi and Lin, 2005).
Here, we demonstrate that OMA-1/2 globally repress tran-
scription in early germline blastomeres, P0 and P1, by a novel
mechanism. We show that OMA-1/2 bind to and sequester in
the cytoplasm TAF-4 (TATA-binding protein associated factor
4), an essential factor required for TFIID formation and function,
thereby repressing all RNA polymerase II-dependent transcrip-
tion. TAF-4 and TAF-12 form specific heterodimers through their
histone fold domains (HFD), and this interaction is required for
proper nuclear localization of TAF-4. OMA-1 binds to the HFD
of TAF-4 via a domain predicted to resemble the structure of
the TAF-12 HFD. We also show that the interaction between
TAF-4 andOMA-1/2 is essential for embryonic viability and is de-
velopmentally regulated, via phosphorylation of OMA-1 at T239
by the kinase MBK-2. This is the same phosphorylation event
that promotes timely degradation of OMA-1. Finally, ectopic
OMA-1 at the four-cell stage can repress transcription in somatic
cells as well as substitute for PIE-1 in transcriptional repression
in the P2 germline blastomere.
RESULTS
OMA-1/2 Interact with TAF-4, a Component
of the TFIID Complex, in Yeast
In yeast two-hybrid screens for OMA-1 interacting proteins,
using the N-terminal 117 amino acids of OMA-1 (OMA-1-N) as
bait, we isolated multiple TAF-4 partial cDNAs. TAFs, along
with TATA box binding protein (TBP), comprise the TFIID tran-
scription complex (Green, 2000;Walker et al., 2001). The interac-
tion with TAF-4 appears to be specific because OMA-1-N did
not interact with seven other TAF proteins examined (Figure S1
available online). OMA-2-N also interacted with TAF-4 with the
same specificity (data not shown). The isolation of TAF-4 as an
OMA-1/2-interacting protein suggested that OMA-1/2 might
function in a process that involves transcriptional activation or
repression.
OMA Proteins Sequester TAF-4 in the Cytoplasm
The transition from oocyte to embryo is rapid and dynamic in
C. elegans. Immediately after fertilization, the oocyte nucleus
completes two rounds of meiosis, generating the oocyte pronu-
cleus. After oocyte and sperm pronuclei decondensation, the
oocyte pronucleus migrates toward the sperm pronucleus, and
soon after the two pronuclei meet, the nuclear envelope breaks
down and the first mitosis begins. Previous antibody staining
showed TAF-4 to be nuclear in oocytes and early blastomeres,
although nuclear TAF-4 staining was not obvious in one- and
two-cell embryos (Walker et al., 2001). We repeated the staining
using the same anti-TAF-4 antibody and observed a ubiquitous
staining in all one-cell and early two-cell embryos and nuclear-
enriched staining at all other embryo stages (Figure 2A). This
Figure 2. OMA-1 and OMA-2 Are Required for Nuclear Enrichment of GFP::TAF-4 in One-Cell Embryos
(A) DIC and GFP fluorescence micrographs of GFP::TAF-4-expressing embryos (first two columns), anti-TAF-4 staining of wild-type embryos (third column),
and anti-GFP and anti-OMA-1 double staining of GFP::TAF-4-expressing embryos (last two columns). DC, pronuclei decondensation; PM, pronuclei meeting.
Arrowhead points to pronuclei in one-cell embryos.
(B) DIC and GFP fluorescence micrographs of animals expressing various GFP-fused transgenic proteins, as indicated below the DIC image. Embryos in the
uterus arrange in a developmental progression from youngest (left) to oldest (right). 1, maturing oocyte.
(C) GFP fluorescence in fixed embryos from transgenic animals expressing GFP::TAF-4 either without (left) or after (right) oma-1(RNAi);oma-2(RNAi). White
arrowheads, two-cell embryos. The two-cell and two one-cell embryos not circled in non-RNAi samples are dividing.
One- and 12-cell embryos are outlined in dashed and solid white lines in (B) and (C). Scale bars represent 25 mm.transient decrease in nuclear TAF-4 in the early embryo coin-
cided closely with the brief period during which OMA proteins
were detected (Figure 2A) (Detwiler et al., 2001; Lin, 2003; Nishi
and Lin, 2005; Shimada et al., 2002). The level of OMA-1 protein
is high in one-cell embryos soon after meiosis but decreases
during the first mitotic cycle. In two-cell embryos, although the
majority of OMA-1 protein has been degraded, a low level
(<10%) can still be detected (Figure S2).
We generated a transgenic strain expressing GFP::TAF-4,
which recapitulated the anti-TAF-4 staining pattern: strong
nuclear GFP fluorescence in oocytes and all blastomeres in
early embryos, with the exception of one-cell and early two-
cell stage embryos, where GFP fluorescence appeared to be
ubiquitous throughout the blastomeres (Figures 2A and 2B;
Figure S3). Quantification of GFP::TAF-4 revealed that both
the intensity of nuclear GFP and the ratio of nuclear to cytoplas-
mic GFP were lower in one-cell embryos than in the most prox-
imal (1) oocyte and later-stage embryos (Figure S3). This in-
verse correlation with OMA-1 level is specific to GFP::TAF-4
because GFP::histone H2B or another TAF, GFP::TAF-12, ex-
pressed from the same expression vector, were predominantly
nuclear throughout early embryogenesis (Figure 2B and
Figure S3D).The inverse correlation between cytoplasmicOMAandnuclear
TAF-4 protein levels suggested that OMA-1/2 might regulate
TAF-4 subcellular localization, or vise versa, in vivo. Depletion
of taf-4 by RNAi in a strain expressing OMA-1::GFP did not result
in any observable defect in OMA-1::GFP localization (data not
shown). However, depletion of oma-1/2did affect TAF-4 localiza-
tion.We observed an increase in nuclear, relative to cytoplasmic,
levels of GFP::TAF-4 in one-cell and early two-cell oma-1(RNAi);
oma-2(RNAi) embryos (Figure 2C; Table S1). oma-1/2 depletion
did not affect the overall level of GFP::TAF-4 or a control GFP-
fusion protein, GFP::PGL-1, expressed from the same vector
(Table S1 and Figure S4). This result is consistent with sequestra-
tion of TAF-4 in the cytoplasm by OMA-1/2, thereby preventing
nuclear enrichment of TAF-4 in the one-cell and early two-cell
embryo.
OMA-1 and OMA-2 Are Required for Transcriptional
Repression in Germline Blastomeres
C. elegans TAF-4 has been shown to be essential for all RNA pol
II transcription examined in the embryo. In taf-4(RNAi) embryos,
no zygotic transcription was detected (Walker et al., 2001). A low
level of nuclear TAF-4 in one- and two-cell embryos could ac-
count for the lack of transcription in these two stages (SeydouxCell 135, 149–160, October 3, 2008 ª2008 Elsevier Inc. 151
Figure 3. OMA-1 and OMA-2 Are Required for Transcriptional
Repression in Germline Blastomeres
(A) Immunofluorescence micrographs of anti-Ser2P staining in wild-type (non-
RNAi), pie-1(RNAi), oma-1(RNAi);oma-2(RNAi), and oma-1(te33);oma-2(RNAi);
pie-1(RNAi) embryos. The background cytoplasmic signals in one-cell (1C)
and two-cell (2C) non-RNAi and pie-1(RNAi) embryos were enhanced to reveal
the outline of embryos. 4C, four-cell embryos.
(B) In situ hybridization of the vet-5 gene. For each embryo, DIC and DAPI
images are shown. Open arrowheads point to pronuclei in 1C, nuclei in 2C,
and the germline nucleus in 4C embryos, respectively.
(C) anti-Ser2P in the gonad of wild-type or oma-1(te33);oma-2(te51) animals.
Oocyte nuclei are indicated by arrows. sp, spermatheca.
(D) Immunofluorescence micrographs of anti-GFP and anti-Ser2P double
staining in embryos expressing GFP::PIE-1. Left two columns, non-RNAi; right
two columns, oma-1(RNAi);oma-2(RNAi).
Scale bars represent 10 mm.152 Cell 135, 149–160, October 3, 2008 ª2008 Elsevier Inc.and Fire, 1994; Walker et al., 2001). We asked whether depletion
of oma-1 and oma-2, which results in elevated nuclear GFP::
TAF-4 levels, would lead to transcription in one- and two-cell
embryos.
In wild-type embryos, markers of transcriptional activity or
products of transcription are first detected in four-cell-stage
embryos, and then only in somatic blastomeres. This is true
whether the assay is performed with an antibody to phosphory-
lated serine 2 of pol II CTD (anti-Ser2P antibody), a marker for
transcriptional elongation (Komarnitsky et al., 2000; Seydoux
andDunn, 1997), or by in situ hybridization to known early zygotic
transcripts (Seydoux and Fire, 1994). In pie-1 mutant or RNAi
embryos, ectopic transcription is detected in germline blasto-
meres P2 and P3 but never in embryos prior to the four-cell stage
(Seydoux et al., 1996). We have reproduced these results (Fig-
ures 3A and 3B).
Double loss-of-functionmutants foroma-1 andoma-2 are ster-
ile. Embryos diminished for oma-1/2 can be obtained, however,
from animals carrying reduction of function mutations [oma-
1(te21);oma-2(te50)] or by RNAi [oma-1(RNAi);oma-2(RNAi)]
(Detwiler et al., 2001; Nishi and Lin, 2005). We analyzed both
Ser2P staining and the expression of vet-5 (very early transcript
5) by in situ hybridization, in oma-1(RNAi);oma-2(RNAi) embryos.
vet-5 is an early zygotic pol II transcript of unknown function
that accumulates in the nucleus (Schauer and Wood, 1990;
Tenenhaus et al., 1998). oma-1(RNAi);oma-2(RNAi) embryos
have severe defects in cell division (Nishi and Lin, 2005), and
therefore we only analyzed one-cell embryos with two clear
pronuclei, prior to the first mitotic division. We detected a clear
anti-Ser2P staining and vet-5-specific signal in one-cell nuclei
of oma-1(RNAi);oma-2(RNAi) embryos (Figures 3A and 3B). The
observed ectopic transcription is not a consequence of dere-
pressed transcription in oocytes of oma-1(RNAi);oma-2(RNAi)
animals because we detected no Ser2P staining in proximal oo-
cytes of oma-1(te33);oma-2(te51) animals, similar to the lack of
Ser2P staining in wild-type proximal oocytes (Walker et al., 2007)
(Figure 3C). These observations indicate that OMA-1 andOMA-2
are required for transcriptional repression in one-cell embryos.
By performing weaker oma-1;oma-2 RNAi, we could obtain
embryos that divided relatively normally beyond the one-cell
stage. In some of these weaker RNAi embryos, we observed
Ser2P staining and vet-5 RNA in all blastomeres, including
AB, P1, P2, and P3 (Figures 3A and 3B, and data not shown).
This result demonstrates that oma-1/2 are required for tran-
scriptional repression not only at the one- to two-cell stage,
but also in germline blastomeres of later-staged embryos. Be-
cause little or no OMA proteins are detected after the two-cell
stage, this requirement for oma-1/2 for transcriptional repres-
sion in P2 and P3 is likely indirect. We believe that OMA-1/2 re-
press transcription in P2 and P3 indirectly by maintaining PIE-1
levels in P blastomeres. Depletion of oma-1/2 results in a loss or
dramatic decrease in PIE-1 levels in RNAi embryos (Figure 3D).
Double staining of GFP::PIE-1 expressing embryos depleted of
oma-1/2 by RNAi revealed an inverse relationship between the
level of GFP::PIE-1 and Ser2P staining in P2 (Figure 3D). Be-
cause depletion of pie-1 does not result in transcription in
one- or two-cell embryos (Seydoux et al., 1996), a reduced
PIE-1 level can not account for the precocious transcription
we observed in one- and two-cell oma-1(RNAi);oma-2(RNAi)
embryos.
Genetic Interaction between OMA-1/2 and TAF-4
Ourmodel predicts that a strain with elevated TAF-4 levels would
bemoresensitive toa reduction inOMA levels. Ina strainexpress-
ing GFP::TAF-4 in addition to endogenous TAF-4, we observed
an increased sensitivity to depletion of oma-1/2 by RNAi com-
pared to control strains expressing either no transgenic protein
(N2) or a control protein (GFP::CYCLIN) driven by the same regu-
latory sequences. Under RNAi conditions that resulted in no ster-
ile animals and no or few dead embryos in the two control strains,
the GFP::TAF-4-expressing strain exhibited approximately 50%
sterile animals and 50% embryonic lethality among those em-
bryos thatwere laid (TableS2). These threestrains showedsimilar
sensitivity to controlRNAiwithanunrelatedgene,wrm-1 (datanot
shown) (Rocheleau et al., 1997). In the GFP::TAF-4-expressing
strain, we observed a strict correlation between the severity of
embryonic lethality with enriched nuclear GFP in one-cell em-
bryos. We interpret the increased sensitivity of the GFP::TAF-4-
expressing strain to oma-1/2 RNAi to be the result of elevated
TAF-4 levels. The in vivo localization and genetic interaction de-
Figure 4. OMA-1 Interacts with TAF-4 His-
tone Fold Domain
(A and B) Deletion analysis to map the TAF-4 (A)
and OMA-1 (B) interaction domains. HFD, histone
fold domain; TAFH, TAF homology domain; ZF,
TIS11 zinc finger. Numbers to the left of each con-
struct indicate amino acid positions. Red dashed
lines demarcate those regions that are necessary
and sufficient for the interaction.
(C) Top: Sequence alignment of the HFD from var-
ious TAF-12 proteins compared to OMA-1 and
OMA-2 sequences including the TAF-4 interacting
domain. Bottom: Sequence alignment of various
TAF-4 proteins. Underlined in red are the regions
necessary and sufficient for interaction. Hs,
human; Dm, D. melanogaster; Sc, S. cerevisiae;
Ce, worm. Yellow highlighting indicates residues
located in the hydrophobic core of the TAF-4/
TAF-12 heterodimer (Werten et al., 2002). a, alpha
helix; L, loop. Amino acids conserved among TAF
proteins are highlighted. Blue, hydrophobic; red,
charged; green, small.
(D) Immunofluorescence micrographs of anti-GFP
and anti-Ser2P double staining or anti-TAF-4
staining in oma-1(te33) embryos expressing
OMA-1 D46-80::GFP that are treated with either
no RNAi or oma-2(RNAi). The scale bar represents
10 mm.
scribed here are consistent with the phys-
ical interaction between OMA proteins
and TAF-4 observed in yeast.
OMA-1/2 and TAF-12 Compete
for Binding to the Histone Fold
Domain of TAF-4
C. elegans TAF-4 contains two domains
conserved among TAF4 proteins, the
N-terminal TAFH/NHR1 domain (amino acids 135–220) and the
C-terminal TAF4 domain (amino acids 346–471) (Walker et al.,
2001). Most TAFs contain an identifiable histone fold domain, he-
lical structures similar to those found in all four core histones,
which mediate specific interactions among the TAFs (review by
Gangloff et al., 2001). The HFD of TAF-4, which resides within
the TAF4 domain, resembles that of histone H2A and interacts
specifically with the TAF-12 HFD, which resembles that of H2B
(Gangloff et al., 2000; Hoffmann and Roeder, 1996; Werten
et al., 2002). We have confirmed that C. elegans TAF-4 and
TAF-12 interact in both a yeast two-hybrid assay and an
in vitro pull-down assay (Figure S1). All taf-4 partial cDNAs iso-
lated in the yeast two-hybrid screen contained the HFD. We fur-
ther mapped the region of TAF-4 necessary and sufficient for
OMA-1/2 interaction to amino acids 333–382, which overlaps
the HFD (Figure 4A and Figure S1B). We found that the HFD re-
gion of TAF-4 was both necessary and sufficient for interaction
with OMA-1, OMA-2, or TAF-12 (data not shown).
The TAF-4/TAF-12 interaction appears to play a key role in the
nuclear enrichment of TAF-4. In taf-12(RNAi) animals, GFP::
TAF-4 was not enriched in any particular subcellular compart-
ment in the gonad or early blastomeres (Figure 5A). SimilarCell 135, 149–160, October 3, 2008 ª2008 Elsevier Inc. 153
ubiquitous localization was observed for TAF-4 deleted of amino
acids 333–382 (GFP::TAF-4DHFD) (Figure 5A). These results
demonstrate that the HFD ofC. elegans TAF-4 mediates interac-
tion with TAF-12 and that this interaction is important for nuclear
enrichment of TAF-4.
The observation that OMA-1 and TAF-12 bind to the same do-
main of TAF-4 suggested that OMA-1/2 would compete with
TAF-12 for binding to TAF-4. We examined this possibility in
mammalian HEK293 tissue culture cells (Figure 5B). When ex-
pressed in HEK293 cells, GFP::TAF-4 was exclusively cytoplas-
mic (100% of GFP-positive cells, n > 1000), whereas HA::TAF-
12 was primarily nuclear (70% of HA-staining cells, n > 1000).
Coexpression of GFP::TAF-4 and HA::TAF-12 resulted in nuclear
localization of GFP::TAF-4 in almost all cells that exhibited nu-
clear HA::TAF-12 (100%, n > 300). The successful recapitula-
tion of TAF-4 and TAF-12 subcellular localization in HEK293 cells
suggests that although TAF-4 and TAF-12 are evolutionarily con-
served, their interaction is species specific. A similar species-
specific interaction of evolutionarily conserved proteins was pre-
viously reported (Francis et al., 2002).
We next asked whether coexpression of OMA-1 N with GFP::
TAF-4 in HEK293 cells would prevent GFP::TAF-4 from undergo-
ing the TAF-12-dependent nuclear enrichment. FLAG::OMA-1-N
is both cytoplasmic and nuclear when expressed in HEK239
cells. Therefore, we tagged FLAG::OMA-1-N at the N terminus
with a myristylation sequence (Myr::FLAG::OMA-1-N), which
tethered OMA-1-N to the underside of the cytoplasmic mem-
brane (Figure 5B). In80% of cells expressing both Myr::FLAG::
OMA-1-N and GFP::TAF-4, we observed GFP fluorescence lo-
calized predominantly to the cytoplasmic membrane (n > 200).
The recruitment of GFP::TAF-4 to the cytoplasmic membrane
occurred even when HA::TAF-12 was also coexpressed in the
same cell (Figure 5B). We observed membrane GFP::TAF-4
and low or no nuclear GFP::TAF-4 in 40% (n > 200) of cells
expressing all three proteins.
The cytoplasmic sequestration of GFP::TAF-4, its TAF-12-
dependent nuclear localization, and its Myr::FLAG::OMA-1-N-
dependent membrane localization all required the TAF-4 HFD.
GFP::TAF-4DHFD was ubiquitous throughout the cell (100%,
n > 1000) and remained so regardless of whether TAF-12 or Myr-
OMA-1-N was coexpressed (Figure 5C). Our results in worms
and HEK293 cells both demonstrate that OMA-1/2 and TAF-12
compete for binding to the same domain of TAF-4.
The TAF-4-Binding Domain of OMA-1
Is Essential for Transcriptional Repression
but Not for Oocyte Maturation
The region of OMA-1 necessary and sufficient for TAF-4 binding
was mapped to a 35 amino acid region (residues 46–80) near the
N terminus (Figure 4B). This region is predicted to exhibit an
a-helical structure by various protein secondary structure pre-
diction programs. Interestingly, this predicted alpha helix, while
sharing no similarity in primary sequence, is similar in secondary
structure to the second alpha helix (a-2) of the TAF-12 HFD
(Gangloff et al., 2001; Werten et al., 2002). Structural studies
identified 13 residues, 11 with hydrophobic and two with a small
side chain, within this second alpha helix that are located in the
hydrophobic core of the TAF-4/TAF-12 heterodimer (Werten154 Cell 135, 149–160, October 3, 2008 ª2008 Elsevier Inc.et al., 2002). Alignment reveals that amino acids 46–80 of
OMA-1 also exhibit hydrophobic residues at ten of these 11 po-
sitions. This similarity is consistent with our above data suggest-
ing that OMA-1 competes with TAF-12 for TAF-4 binding.
To test whether the observed ectopic transcription in oma-1/2-
depleted embryos was indeed due to a defect in TAF-4 seques-
tration, we assayed the function of OMA-1 lacking the 35 amino
acid TAF-4-interacting domain in vivo. We generated transgenic
animals expressing either wild-type OMA-1::GFP or OMA-1::
GFP deleted of amino acids 46–80 (OMA-1 D46-80::GFP) in the
oma-1(te33) background. Both transgenic strains are healthy
and exhibit no abnormal phenotype. We then depleted oma-2
by RNAi in animals carrying either transgene, or no transgene,
and assayed for (1) oocyte maturation defect (Oma), (2) percent-
age of dead embryos, (3) anti-Ser2P staining, and (4) anti-TAF-4
staining.
We observed that both wild-type OMA-1::GFP and OMA-1
D46-80::GFP rescued the oocyte maturation defect, as 100% of
transgenic animals (n > 500) remained fertile upon oma-2(RNAi),
compared to 0% of nontransgenic animals (n > 500). However,
only wild-type OMA-1::GFP, and not OMA-1 D46-80::GFP, res-
cued the embryonic lethality of oma-1(te33);oma-2(RNAi) em-
bryos (50%, n = 551, and 0%, n > 2000, respectively). Embryonic
lethality correlated with nuclear enrichment of TAF-4 and ectopic
transcription in one- and two-cell embryos. The majority of one-
cell (83%, 24 of 29) and two-cell (96%, 27 of 28) embryos ex-
pressing OMA-1 D46-80::GFP had detectable Ser2P staining
(Figure 4D). This is in contrast to the 0% Ser2P staining observed
in non-oma-2(RNAi) controls. Embryos expressing wild-type
OMA-1::GFP have detectable Ser2P staining in 26% (5 of 19)
and 50% (9 of 18) of one-cell and two-cell embryos, respectively.
These results lead to three major conclusions. First, the function
of OMA-1 in oocytes and embryos can be uncoupled, further sup-
porting our earlier conclusion that the observed transcription in
oma-1(RNAi);oma-2(RNAi) embryoswas not due to compromised
oocytematuration. Second, TAF-4-binding is essential for OMA-1
function in embryos but not in oocytes. Third, OMA-1 represses
transcription by binding to TAF-4. This result does not rule out
an additional function(s) for OMA-1/2 in one-cell embryos. In
fact, embryos depleted of oma-1 and oma-2 by RNAi exhibit
a more severe defect in embryonic divisions than do OMA-1
D46-80::GFP-expressing embryos, suggesting that OMA pro-
teins might have an additional embryonic function(s).
Interaction between OMA-1 and TAF-4
Is Regulated by MBK-2
Two observations suggested that the interaction between OMA-
1/2 and TAF-4 is regulated. First, although OMA-1/2 proteins are
present at a high level in both oocytes and the one-cell embryo,
cytoplasmic sequestration of TAF-4 is only observed in the em-
bryo. Second, we observed that whereas Myr::FLAG::OMA-1-N
effectively recruited GFP::TAF-4 to the cell membrane, Myr::
FLAG::OMA-1-FL (full length) did so very poorly (8%, n = 50, Fig-
ures 5B and 6C). One candidate regulator of the OMA-1/TAF-4
interaction is MBK-2, which is activated at meiosis II and has
been shown to phosphorylate OMA-1 and OMA-2 (Nishi and
Lin, 2005; Pellettieri et al., 2003; Shirayama et al., 2006). The fol-
lowing three results demonstrate that the interaction between
OMA-1/2 and TAF-4 is a developmentally regulated event and
that MBK-2 phosphorylation of OMA-1 at T239 facilitates this
interaction. First, we performed mbk-2(RNAi) in GFP::TAF-4-
expressing animals and observed an increase in nuclear GFP::
TAF-4 in one-cell embryos (Figure 6A). When these embryos
were costained with anti-Ser2P and anti-GFP antibodies, we ob-
served a strong correlation between high levels of nuclear GFP::
Figure 5. OMA-1 Competes with TAF-12 for TAF-4 Binding
(A) GFP fluorescence in the gonad (dashed line) and embryos of transgenic
worms expressing GFP::TAF-4, GFP::TAF-4DHFD, or GFP::TAF-4 with taf-
12(RNAi).
(B) HEK293 cells expressing TAF-4 (green) alone, TAF-4+TAF-12 (magenta),
TAF-4+MYR::OMA-1-N (red), or TAF-4+TAF-12+MYR::OMA-1-N.
(C) TAF-4DHFD expressed alone, with TAF-12, or with Myr::OMA-1-N.
The scale bar represents 25 mm.TAF-4 and Ser2P staining in one-cell embryos (100%, n = 30,
Figure 6B). Second, we have shown previously that the oma-
1(zu405)mutation (P240L) interferes with MBK-2 phosphorylation
of OMA-1 at T239, thereby preventing OMA-1 from being de-
graded after the one-cell stage. oma-2(RNAi) in the oma-
1(zu405) background resulted in a similar increase in
GFP::TAF-4 in one-cell nuclei (Figure 6A). Third, coexpression
of MBK-2 with Myr::FLAG::OMA-1-FL and GFP::TAF-4 in
HEK293 cells significantly increased cell membrane localization
of GFP::TAF-4 (48%, n = 50), compared to cells either express-
ing no MBK-2 or coexpressing a kinase-dead version of MBK-2
(16%, n = 50) (Figure 6C). This enhancement by MBK-2 was de-
pendent on T239 because no enhancement was observed when
Myr::FLAG::OMA-1-FL T239A was expressed (12%, n = 50)
(Figure 6C).
Ectopic OMA-1 Expression Can Repress Transcription
in Later Somatic and Germline Blastomeres
We asked whether OMA-1, under conditions permitting its per-
sistence beyond the one-cell stage [mbk-2(RNAi), oma-1(zu405);
oma-2(RNAi), and cul-1(RNAi)], could sequester TAF-4 or re-
press transcription in later-stage embryos. In both mbk-2(RNAi)
and oma-1(zu405);oma-2(RNAi) embryos, in which OMA pro-
teins are compromised in MBK-2 phosphorylation (Nishi and
Lin, 2005), we did not observe a reduced nuclear GFP level at
four- to 12-cell stages (Figure S5). CUL-1 has been shown to
be required for the timely degradation of OMA-1 but not for any
MBK-2-dependent event (Kipreos et al., 1996; Shirayama et al.,
2006). We observed that 100% (n = 14) of cul-1(RNAi) animals
exhibited OMA-1::GFP in embryos as late as the 12-cell stage
(Figure 7A). Unlikembk-2(RNAi) and oma-1(zu405);oma-2(RNAi),
cul-1(RNAi) resulted in an observable reduction in nuclear
GFP::TAF-4 in four-cell embryos (64%, n = 14). In addition, very
low or no Ser2P staining was detected in all blastomeres in
77% (n = 18) of four-cell cul-1(RNAi) embryos (Figure 7B). When
cul-1(RNAi) was performed together with oma-2(RNAi) in the
oma-1(te33) background, we detected only 18% (n = 17) of
four-cell embryos with low or no Ser2P staining, whereas the
other 82% of embryos had Ser2P in somatic nuclei. This result
argues that the effect of cul-1(RNAi) is dependent on both
oma-1 and oma-2. In control experiments where cul-
1(RNAi);oma-1(RNAi) was performed in oma-1(te33) animals,
we observed 66% of four-cell embryos with low or no Ser2P
staining (n = 8).
We then asked whether persisting OMA-1 in cul-1(RNAi) em-
bryos could substitute for PIE-1 in germline transcriptional re-
pression. In pie-1(RNAi) embryos, transcription is derepressed
in the P2 blastomere, whereas in cul-1(RNAi);pie-1(RNAi) em-
bryos, transcription remains repressed in the P2 blastomere,
as indicated by a lack of Ser2P staining (67%, n = 12; Figure 7B).
This result was not due to inefficient pie-1 RNAi in double RNAi
embryos because we detected Ser2P staining in 100% (n = 11,
Figure 7B) of P2 blastomeres in pie-1(RNAi);oma-2(RNAi) em-
bryos. All together, these results indicate that persisting OMA-
1, if properly phosphorylated by MBK-2, can repress transcrip-
tion in both somatic and germline blastomeres in later-stage
embryos.Cell 135, 149–160, October 3, 2008 ª2008 Elsevier Inc. 155
Figure 6. Interaction between OMA-1 and TAF-4 Is Regulated by MBK-2
(A) Top three rows: GFP fluorescence in utero of embryos expressing GFP::TAF-4 in genetic backgrounds listed to the left. Bottom row: persistence of
GFP::OMA-1 fluorescence after mbk-2(RNAi). Arrows mark one-cell embryos.
(B) Immunofluorescencemicrographs of anti-Ser2P and anti-GFP double staining in one-cell embryos expressingGFP::TAF-4 either with or withoutmbk-2(RNAi).
(C) Confocal immunofluorescence micrographs of Myr::OMA-1-FL, GFP::TAF-4, DAPI, and all three (merged) in HEK239 cells. Proteins expressed from trans-
fected constructs are indicated on the left. KD, kinase dead. The localization of Myr-OMA-1-FL (cytoplasmic membrane and cytoplasmic aggregates that
were observed when high levels of Myr-tagged proteins were expressed) is not affected by MBK-2 activity.
Scale bars represent 25 mm (A) and 10 mm (B).DISCUSSION
The paradigm for global transcriptional repression of germline
precursors in C. elegans is PIE-1. PIE-1 represses transcription
in P2, P3, and, to a certain extent, in P4 (Seydoux et al., 1996)
by repressing both transcriptional initiation and elongation (Sey-
doux and Dunn, 1997; Ghosh and Seydoux, 2008). We propose
here that OMA-1 and OMA-2 have redundant functions in global
repression of transcription in P0 and P1 by a distinct mechanism.
OMA-1/2 bind to TAF-4, sequestering TAF-4 in the cytoplasm.
We further propose that this interaction occurs only in embryos
where it is facilitated by phosphorylation of OMA-1 and OMA-2
by MBK-2, a modification also marking both OMA proteins for
eventual degradation (Nishi and Lin, 2005). Upon OMA degrada-
tion, TAF-4 is released and bound by TAF-12, the TAF-4/12 het-
erodimer translocates to the nucleus, and transcriptional repres-
sion is relieved.
Recognition and binding of the TATA box by TFIID is a major
rate-limiting step in transcription initiation by RNA polymerase
II (Chatterjee and Struhl, 1995; Klages and Strubin, 1995). There
is an approximate 10 min delay between the time when most
OMA protein is degraded (the end of the first mitosis) and when
zygotic transcription is first detected (the four-cell embryo). We
propose that this delay reflects the time it takes (1) for the residual
amount of OMA proteins to degrade in two-cell embryos
(Figure S2), (2) for the TAF-4/TAF-12 dimer to form in the cyto-156 Cell 135, 149–160, October 3, 2008 ª2008 Elsevier Inc.plasmand translocate to the nucleus, (3) for a fully functional TFIID
complex to assemble at the TATA box, and (4) for transcription to
reach experimentally detectable levels. Finally, we also propose
that OMA-1 and OMA-2 are indirectly required for transcriptional
repression in later germline blastomeres by regulating PIE-1
levels.
Developmental Regulation of OMA-1 andOMA-2Activity
Regulation of the OMA/TAF-4 interaction via MBK-2-dependent
phosphorylation prevents cytoplasmic sequestration of TAF-4
until after meiosis II. This temporal regulation is apparently
not to prevent TAF-4 from being sequestered in oocytes, as
the oocytes are already transcriptionally repressed through
a yet-to-be-determined mechanism (Walker et al., 2007). It is
possible that TAF-4 binding is incompatible with OMA-1/2
function(s) in oocyte maturation. For example, the binding of
OMA-1 to TAF-4 in oocytes might preclude the interaction of
OMA-1 with other binding partners. Phosphorylation of OMAs
by MBK-2 might serve to switch OMA-1 and OMA-2 from being
regulators of oocyte maturation to transcriptional repressors,
albeit relatively short-lived ones. We propose that MBK-2 phos-
phorylation either results in a change in conformation of OMA-
1/2 that renders their N-terminal domains more accessible or
changes the affinity between OMA-1/2 and different binding
partners. Because OMA-1 P240L persisted past the one-cell
stage and could be suppressed by oma-1(RNAi) (Lin, 2003;
Nishi and Lin, 2005), zu405 was originally considered a gain-
of-function mutation. However, our results here demonstrate
that zu405 is also a loss-of-function or reduction-of-function al-
lele with respect to TAF-4 sequestration and transcriptional
repression.
The interaction between OMA-1/2 and TAF-4 is probably
also regulated by breakdown of the oocyte nuclear envelope
during oocyte maturation, which occurs slightly before MBK-
2 activation (Nishi and Lin, 2005; Pellettieri et al., 2003; Stitzel
et al., 2006). Nuclear envelope breakdown would result in
OMA-1, OMA-2, and TAF-4 proteins occupying, for the first
time, the same subcellular compartment. OMA-1/2 interaction
with TAF-4, after OMA phosphorylation by MBK-2, would se-
quester TAF-4 in the cytoplasm when the nuclear membrane
reforms.
Redundancy of Transcriptional Repression
in Primordial Germ Cells
The similarities between PIE-1 and the OMA proteins are in-
triguing. They all are multifunctional proteins, contain two
Figure 7. Ectopic OMA-1 in cul-1-Depleted Embryos
Can Repress Transcription
(A) GFP fluorescence and corresponding DIC images of four-
cell embryos expressing GFP::TAF-4 and embryos in utero
expressing GFP::OMA-1 with or without cul-1(RNAi). Arrow,
one-cell embryo; arrowhead, four-cell embryo.
(B) Immunofluorescence micrographs of anti-Ser2P and anti-
OMA-1 double staining in four-cell embryos of the follow-
ing backgrounds: no RNAi, cul-1(RNAi), cul-1(RNAi);oma-
1(te33);oma-2(RNAi), cul-1(RNAi);oma-1(te33);oma-1(RNAi),
pie-1(RNAi);cul-1(RNAi), or pie-1(RNAi);oma-2(RNAi).
Scale bars represent 20 mm (A) and 10 mm (B).
TIS11 CCCH zinc fingers that may function in
RNA binding, and repress transcription through
domains distinct from their zinc fingers (Detwiler
et al., 2001; Jadhav et al., 2008; Mello et al.,
1996; Tenenhaus et al., 2001; Zhang et al.,
2003). We are currently investigating whether
OMA-1 and OMA-2 regulate PIE-1 levels
through a CCCH finger-dependent, RNA-binding
mechanism. We propose that PIE-1 and OMA pro-
teins have partially redundant functions, albeit
through different mechanisms, in transcriptional
repression in germline blastomeres. Their func-
tions are temporally and spatially restricted by
their respective expression patterns. There is in-
creasing evidence that transcriptional repression
in PGCs often involves redundant or partially re-
dundant mechanisms. In Drosophila, transcrip-
tional repression in germ cells involves epigenetic
chromatin marks as well as several partially re-
dundant factors (Deshpande et al., 2004, 2005;
Leatherman et al., 2002; Martinho et al., 2004;
Schaner et al., 2003). It was recently shown that
Drosophila polar granule component (Pgc) also in-
hibits the p-TEFb complex, thereby repressing
transcription in germ cells (Hanyu-Nakamura et al., 2008). How-
ever, PIE-1 and Pgc inhibit different subunits of the p-TEFb
complex.
TAF-4 as a Target for Transcriptional Repression
Of the multiple TAFs required for TFIID complex assembly
in vitro, TAF-4 is the most crucial (Wright et al., 2006). In C. ele-
gans, taf-4(RNAi) results in the most severe taf depletion pheno-
type, similar to depletion of RNA polymerase II (Walker and
Blackwell, 2003; Walker et al., 2001; Walker et al., 2004). There-
fore, efficient inactivation of TAF-4 would be an effective way to
repress global transcription by RNA pol II. TAF-4 has been pro-
posed as a target of several mutant proteins resulting from poly-
glutamine expansion (Shimohata et al., 2000), the causative
mutation in at least eight neurodegenerative disorders. The
polyQ expansions of mutant Huntington protein and atrophin-1
bind to and sequester TAF-4 within intranuclear inclusions, pre-
venting transcription in certain neurons or tissue culture cells
(Dunah et al., 2002; Shimohata et al., 2000). It is important to
note that OMA proteins sequester TAF-4 through a domain ofCell 135, 149–160, October 3, 2008 ª2008 Elsevier Inc. 157
TAF-4 distinct from that targeted by polyQ-expanded proteins,
and under physiological, rather than pathological, conditions.
Transcription Repression in C. elegans Germline
Blastomeres
Dynamic and readily reversible mechanisms of transcriptional
repression are crucial in C. elegans germline blastomeres. Con-
sistent with this notion, chromatin in germline blastomeres
exhibit epigenetic marks characteristic of transcriptionally com-
petent chromatin (Schaner et al., 2003). PIE-1 and OMA-1/2
provide an effective means for repressing transcriptionally com-
petent chromatin in a way that is both dynamic and easily re-
versed. Asymmetric segregation of PIE-1 to the germline blasto-
mere facilitates rapid resumption of transcription in the somatic
sister cell, presumably from preexisting pol II preinitiation com-
plexes (Reese et al., 2000; Seydoux and Dunn, 1997; Seydoux
et al., 1996; Zhang et al., 2003). Rapid degradation of OMA-1/2
allows the TAF-4/TAF-12 interaction and transcription to occur
within the next cell cycle or two.
C. elegansgermline blastomeres resemble stemcells in certain
ways. Stem cells are generally defined as cells that can both self-
renew and generate progeny that have restricted developmental
or differentiation potentials. One common feature of stem cells is
their ability to repress the expression of genes associated with
lineage-specific differentiation. Accumulating data suggest a
model whereby important tissue-specific regulator genes are
‘‘primed’’ for expression in pluripotent cells (Giadrossi et al.,
2007; Spivakov and Fisher, 2007) but their expression is ‘‘held
back’’ by various mechanisms. Mechanisms of ‘‘holding back’’
include opposing histone modifications (Azuara et al., 2006;
Bernstein et al., 2006; Stock et al., 2007) and active degradation
of specific transcription factors by proteasomes (Szutorisz et al.,
2006). Our study on OMA-1/2 and others on PIE-1 could shed
light on additional mechanism(s) by which transcription can be
repressed in vertebrate stem cells.
EXPERIMENTAL PROCEDURES
Strains
N2 was used as the wild-type strain. Genetic markers were as follows: LGIII,
unc-119(ed3); LGIV, oma-1(zu405), oma-1(te33), oma-1(te21); and LGV, oma-
2(te50), oma-2(te51). Transgenic strains were generated by microparticle
bombardment (Praitis et al., 2001) of the respective plasmids: Ppie-1gfp::taf-4
in TX903 (teIs90), Ppie-1gfp::taf-4D333-382 in TX909 (teIs96), Ppie-1gfp::taf-12
in TX1014 (teIs102), Poma-1oma-1::gfp in TX864 (teIs76; te33), and Poma-1oma-
1D46-80::gfp in TX1155 (teEx559; te33) and TX1162 (teIs108; te33). TX189,
ET113, and AZ212 contain Poma-1oma-1::gfp, Ppie-1gfp::cyb-1 and Ppie-1gfp::
h2b transgenes, respectively, as described (Lin, 2003; Liu et al., 2004; Praitis
et al., 2001).
Plasmid Construction
Partial cDNA for taf-1 and full-length cDNAs for taf-4, taf-5, taf-6.1, and taf-10
were amplified from yk14c2, yk326f12, yk1669h05, yk850e10, and yk1035 g02
clones, respectively. Full-length cDNAs for taf-8, taf-9, and taf-12 were ampli-
fied from embryos by RT-PCR. Most plasmids were constructed with the
Gateway cloning technology. Germline expression constructs were derived
from pID3.01B (Reese et al., 2000) or from pRL475 (Lin, 2003).
RNA Interference
Feeding RNAi was performed as described (Timmons and Fire, 1998). In all
cases, L1 larvae were placed on plates containing feeding RNAi bacteria, incu-158 Cell 135, 149–160, October 3, 2008 ª2008 Elsevier Inc.bated at either 20 or 25C, and scored 3 days later. Serial dilutions with the
host strain HT115 were performed for the generation of weaker RNAi. RNAi
of taf-1, taf-5, taf-6.1, taf-7.1, taf-8, taf-9, taf-10, and taf-12 was performed
by injection of dsRNA into the TX903 strain, and GFP::TAF-4 expression ana-
lyzed 24 and 48 hr later. A dramatic reduction of nuclear and overall GFP was
observed 24 hr after injection of taf-12 dsRNA and 48 hr after injection of the
other taf dsRNAs, suggesting that depletion of any of the taf genes eventually
affects localization of TAF-4.
Transfection Assay
HEK293T cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM)
with 10% fetal bovine serum (FBS) on 1.5 mm coverslips and transfected 16 hr
later with the Fugene 6 (Roche) kit with 1 mg total DNA. Transfected cells were
fixed for staining 24 hr to 48 hr later. TAF-4, TAF-12, andOMA-1 were all driven
by the cytomegalovirus (CMV) promoter and tagged N-terminally with GFP,
33 HA, and Myr-FLAG, respectively. The Myr sequence used was MGSNKS
KPKDASQ. MBK-2 and kinase-dead MBK-2 (Y237A) were not tagged (Nishi
and Lin, 2005; Shirayama et al., 2006).
Immunofluorescence
Immunofluorescence protocols for C. elegans embryos was as follows: anti-
Ser2P (1/300, Covance, MMS-129R, [Seydoux and Dunn, 1997]), anti-PIE-1
(1/50, [Mello et al., 1996]), anti-OMA-1 (anti-OMA-1a, 1/100, [Shimada et al.,
2002]), anti-TAF-4 (1/100, [Walker et al., 2001]), and anti-GFP (1/250, Invitro-
gen [both rabbit and mouse] [Lin et al., 1998]). Immunofluorescence staining
of HEK293 cells was as described (Hao et al., 2006). Antibodies used were
rabbit anti-GFP, mouse anti-FLAG (1/250, Sigma, F3165), rat anti-HA (1/50,
Roche, 3F10), goat anti-rabbit Alexa488, goat anti-mouse Alexa568, and goat
anti-rat Alexa647 (Invitrogen).
In Situ Hybridization
In situ hybridization for vet-5 was as described (Seydoux and Fire, 1995) with
the exception that one-cell images were obtained by dissection of mothers in
PBS on polylysine-treated teflon slides rather than by hypochlorite treatment.
oma-1(RNAi);oma-2(RNAi) embryos were not compatible with hypochlorite
treatment. The vet-5 probe was synthesized by PCR from pC101 with the
DIG probe synthesis kit (Roche). Anti-DIG-AP antibody (Roche, 1/2000) was
used, followed by NBT/BCIP (Roche) color reaction.
Analysis of Embryos, Imaging, and Quantification
Imaging of immunofluorescence, in situ, and live embryos was performed with
an Axioplan microscope (Zeiss) equipped with a MicroMax-512EBFT CCD
camera (Princeton Instruments) controlled by the Metamorph acquisition soft-
ware (Molecular Devices). Imaging of HEK293 cells was performed with a LSM
510 Meta confocal microscope (Zeiss). The percentage of embryos at meiosis
I, meiosis II, one-cell, two-cell, and four-cell stages were determined by DAPI
staining and shown to be comparable between oma-1(te33);oma-2(RNAi);-
teIs108 and oma-1(te33); teIs76 (Table S3).
Yeast Two-Hybrid Screen and Assay
Yeast two-hybrid screens were performed with the GAL4-based transcription
system, with OMA-1-N expressed from pGBKT7 as bait. A C. elegans mixed-
stage library (Z. Zhou and R. Horvitz, personal communication) was screened
on 50 mM 3AT (3-amino-1,2,4-triazole) Trp Leu His plates. Four positive
clones encoding the C-terminal 235, 287, 317, and 321 amino acids of the
TAF-4 protein were isolated from approximately 3.5 million transformants.
For all assays described here, pGBKT7 and a pASII-derived Gateway plasmid
were used for bait vectors, and a pACTII-derived Gateway plasmid was used
for prey vector.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, five fig-
ures, and three tables and can be found with this article online at http://
www.cell.com/cgi/content/full/135/1/149/DC1/.
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